Correlation Between SanBio Company and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both SanBio Company and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SanBio Company and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SanBio Company Limited and Rigel Pharmaceuticals, you can compare the effects of market volatilities on SanBio Company and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SanBio Company with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SanBio Company and Rigel Pharmaceuticals.
Diversification Opportunities for SanBio Company and Rigel Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between SanBio and Rigel is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding SanBio Company Limited and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and SanBio Company is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SanBio Company Limited are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of SanBio Company i.e., SanBio Company and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between SanBio Company and Rigel Pharmaceuticals
Assuming the 90 days horizon SanBio Company Limited is expected to under-perform the Rigel Pharmaceuticals. But the otc stock apears to be less risky and, when comparing its historical volatility, SanBio Company Limited is 19.68 times less risky than Rigel Pharmaceuticals. The otc stock trades about -0.04 of its potential returns per unit of risk. The Rigel Pharmaceuticals is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 1,140 in Rigel Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of 1,621 from holding Rigel Pharmaceuticals or generate 142.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.6% |
| Values | Daily Returns |
SanBio Company Limited vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| SanBio Limited |
| Rigel Pharmaceuticals |
SanBio Company and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SanBio Company and Rigel Pharmaceuticals
The main advantage of trading using opposite SanBio Company and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SanBio Company position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| SanBio Company vs. Rigel Pharmaceuticals | SanBio Company vs. Geron | SanBio Company vs. Verastem | SanBio Company vs. Immutep Ltd ADR |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |